$NEUP
Neuphoria Therapeutics Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$3.70
▼-0.40%-$0.015
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateNeuphoria Therapeutics Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is NEUP down today? It is at $3.70 (-0.40%). See the catalyst behind the move, real-time alerts the moment NEUP spikes, and full due diligence on NEUP — key stats, earnings, dilution and insider activity. Free.
Be first to know when $NEUP makes an unusual move. Create a free account to track $NEUP, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on NEUP from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for NEUP today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystNeuphoria Therapeutics Inc.: FY2026 results, year to Jun 30, 2026, from an SEC filing. Read it →Latest filingDEFA14AAdditional proxy materialSep 18, 2026 · yesterday| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Lynx1 Capital Management Lp Beneficial Owner (10%) | Bought (open market) | +639K 11.8% of company | added 100% | 875K | $3.3M at $5.14 | Oct 21, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on NEUP from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for NEUP today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
NEUP last traded at $3.70, down 0.40% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Neuphoria Therapeutics Inc. Common Stock (NEUP) is next expected to report earnings on Monday, October 5, 2026, about 15 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The NEUP Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged NEUP 0 times in the last 30 days.
NEUP (Neuphoria Therapeutics Inc. Common Stock) trades on XNAS, with a market cap of about $20M in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge NEUP for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$NEUP discussion
Sign in to ask a question or join the discussion.